MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice

MALDI Imaging mass spectrometry has entered the field of tissue-based research by providing unique advantages for analyzing tissue specimen in an unprecedented detail. A broad spectrum of analytes ranging from proteins, peptides, protein modification over small molecules, drugs and their metabolites as well as pharmaceutical components, endogenous cell metabolites, lipids, and other analytes are made accessible by this in situ technique in tissue. Some of them were even not accessible in tissues within the histological context before. Thereby, the great advantage of MALDI Imaging is the correlation of molecular information with traditional histology by keeping the spatial localization information of the analytes after mass spectrometric measurement. This method is label-free and allows multiplex analysis of hundreds to thousands of molecules in the very same tissue section simultaneously. Imaging mass spectrometry brings a new quality of molecular data and links the expert discipline of pathology and deep molecular mass spectrometric analysis to tissue-based research. This review will focus on state-of-the-art of MALDI Imaging mass spectrometry, its recent applications by analyzing tissue specimen and the contributions in understanding the biology of disease as well as its perspectives for pathology research and practice.

[1]  L. Liotta,et al.  Laser capture microdissection. , 2006, Methods in molecular biology.

[2]  R. Caprioli,et al.  Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.

[3]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[4]  I. Vorobyov,et al.  Glycero- versus sphingo-phospholipids: correlations with human and non-human mammalian lens growth. , 2003, Experimental eye research.

[5]  Peter Olson,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0288 Minireview: Lipid Metabolism, Metabolic Diseases, and , 2022 .

[6]  M. Karas,et al.  Ion Formation in MALDI: The Cluster Ionization Mechanism , 2003 .

[7]  S. Culine,et al.  Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002) , 2003, British Journal of Cancer.

[8]  D. Borchman,et al.  Isolation and lipid characterization of cholesterol-enriched fractions in cortical and nuclear human lens fibers. , 2003, Investigative ophthalmology & visual science.

[9]  Walter A. Korfmacher,et al.  Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. , 2003, Journal of mass spectrometry : JMS.

[10]  F. Halgand,et al.  Tissue molecular ion imaging by gold cluster ion bombardment. , 2004, Analytical chemistry.

[11]  M. Yappert,et al.  In situ MALDI-TOF MS regional analysis of neutral phospholipids in lens tissue. , 2004, Analytical chemistry.

[12]  C. Abrass.  Cellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease , 2004, American Journal of Nephrology.

[13]  A. Woods,et al.  In situ structural characterization of phosphatidylcholines in brain tissue using MALDI-MS/MS , 2005, Journal of the American Society for Mass Spectrometry.

[14]  N. Pavlidis,et al.  Cancer of unknown primary (CUP). , 2005, Critical reviews in oncology/hematology.

[15]  Markus Stoeckli,et al.  MALDI mass spectrometric imaging of biological tissue sections , 2005, Mechanisms of Ageing and Development.

[16]  R. Caprioli,et al.  Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. , 2006, Analytical chemistry.

[17]  Carissa A. Sanchez,et al.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.

[18]  Michelle L. Reyzer,et al.  MALDI imaging mass spectrometry: molecular snapshots of biochemical systems , 2007, Nature Methods.

[19]  Mariaelena Pierobon,et al.  Laser capture microdissection technology , 2007, Expert review of molecular diagnostics.

[20]  Joseph L. Cantone,et al.  Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues. , 2007, Journal of pharmacological and toxicological methods.

[21]  M. Clench,et al.  Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix-assisted laser desorption/ionisation mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.

[22]  Michelle L. Reyzer,et al.  MALDI-MS-based imaging of small molecules and proteins in tissues. , 2007, Current Opinion in Chemical Biology.

[23]  L. Signor,et al.  Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometry. , 2007, Journal of mass spectrometry : JMS.

[24]  Pierre P Massion,et al.  High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometry , 2008, Proteomics.

[25]  R. Reznek,et al.  Cancer of unknown primary site. , 2008, Clinical medicine.

[26]  Protein fragment imaging using ink jet printing digestion technique , 2008 .

[27]  P. Chaurand,et al.  Imaging mass spectrometry of intact proteins from alcohol-preserved tissue specimens: bypassing formalin fixation. , 2008, Journal of proteome research.

[28]  J. A. Fernández,et al.  Profiling and imaging of lipids on brain and liver tissue by matrix-assisted laser desorption/ ionization mass spectrometry using 2-mercaptobenzothiazole as a matrix. , 2008, Analytical chemistry.

[29]  Mitsutoshi Setou,et al.  Imaging Mass Spectrometry for Visualization of Drug and Endogenous Metabolite Distribution: Toward In Situ Pharmacometabolomes , 2010, Journal of Neuroimmune Pharmacology.

[30]  I. Fournier,et al.  Improving tissue preparation for matrix-assisted laser desorption ionization mass spectrometry imaging. Part 1: using microspotting. , 2009, Analytical chemistry.

[31]  Richard A Yost,et al.  Imaging of lipids in spinal cord using intermediate pressure matrix-assisted laser desorption-linear ion trap/Orbitrap MS. , 2009, Analytical chemistry.

[32]  S. Mikawa,et al.  Imaging of phosphatidylcholines in the adult rat brain using MALDI-TOF MS , 2009, Neuroscience Letters.

[33]  Hua Yu,et al.  MALDI reveals membrane lipid profile reversion in MDX mice , 2009, Neurobiology of Disease.

[34]  Richard M Caprioli,et al.  Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation[S] , 2009, Journal of Lipid Research.

[35]  Y. Kimura,et al.  Organ-Specific Distributions of Lysophosphatidylcholine and Triacylglycerol in Mouse Embryo , 2009, Lipids.

[36]  Robert C Murphy,et al.  Imaging of lipid species by MALDI mass spectrometry This work was supported in part by the Lipid MAPS Large Scale Collaborative Grant from the National Institutes of Health (GM-069338). Published, JLR Papers in Press, December 2, 2008. , 2009, Journal of Lipid Research.

[37]  M. Setou,et al.  Visualization of the cell-selective distribution of PUFA-containing phosphatidylcholines in mouse brain by imaging mass spectrometry[S] , 2009, Journal of Lipid Research.

[38]  T. Garrett,et al.  Lipid geographical analysis of the primate macula by imaging mass spectrometry. , 2009, Methods in molecular biology.

[39]  I. Fournier,et al.  MALDI imaging and profiling MS of higher mass proteins from tissue , 2010, Journal of the American Society for Mass Spectrometry.

[40]  R. Caprioli,et al.  Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation , 2010, Clinical Cancer Research.

[41]  Thomas E. Fehniger,et al.  Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry , 2010, PloS one.

[42]  P. Kochanek,et al.  Mass‐spectrometry based oxidative lipidomics and lipid imaging: applications in traumatic brain injury , 2010, Journal of neurochemistry.

[43]  Kristina Schwamborn,et al.  Molecular imaging by mass spectrometry — looking beyond classical histology , 2010, Nature Reviews Cancer.

[44]  G. La Torre,et al.  Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[45]  Michelle L. Reyzer,et al.  Direct molecular analysis of whole-body animal tissue sections by MALDI imaging mass spectrometry. , 2010, Methods in molecular biology.

[46]  M. Clench,et al.  Novel molecular tumour classification using MALDI–mass spectrometry imaging of tissue micro-array , 2010, Analytical and bioanalytical chemistry.

[47]  V. Havlíček,et al.  Visualizing spatial lipid distribution in porcine lens by MALDI imaging high-resolution mass spectrometry , 2010, Journal of Lipid Research.

[48]  Andreas Kowarsch,et al.  Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier. , 2010, Journal of proteome research.

[49]  Zoltan Takats,et al.  Histology by mass spectrometry: label-free tissue characterization obtained from high-accuracy bioanalytical imaging. , 2010, Angewandte Chemie.

[50]  I. Fournier,et al.  Liquid ionic matrixes for MALDI mass spectrometry imaging of lipids. , 2010, Journal of proteomics.

[51]  M. Ohmura,et al.  Paradoxical ATP elevation in ischemic penumbra revealed by quantitative imaging mass spectrometry. , 2010, Antioxidants & redox signaling.

[52]  M. Setou,et al.  Imaging mass spectrometry of gastric carcinoma in formalin‐fixed paraffin‐embedded tissue microarray , 2010, Cancer science.

[53]  A. Rosenwald,et al.  Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma , 2010, Journal of Cancer Research and Clinical Oncology.

[54]  Brendan Prideaux,et al.  Applications of MALDI-MSI to pharmaceutical research. , 2010, Methods in molecular biology.

[55]  L. Quinton,et al.  Mass spectrometry imaging of rat brain sections: nanomolar sensitivity with MALDI versus nanometer resolution by TOF–SIMS , 2010, Analytical and bioanalytical chemistry.

[56]  Detlev Suckau,et al.  Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. , 2010, Journal of proteome research.

[57]  B. Colsch,et al.  Localization and imaging of sialylated glycosphingolipids in brain tissue sections by MALDI mass spectrometry. , 2010, Glycobiology.

[58]  H. Utsumi,et al.  Ultrahighly sensitive in situ metabolomic imaging for visualizing spatiotemporal metabolic behaviors. , 2010, Analytical chemistry.

[59]  André M Deelder,et al.  Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity , 2010, The Journal of pathology.

[60]  M. Snel,et al.  High-spatial resolution matrix-assisted laser desorption ionization imaging analysis of glucosylceramide in spleen sections from a mouse model of Gaucher disease. , 2010, Analytical chemistry.

[61]  Marc K Halushka,et al.  Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer. , 2010, Human pathology.

[62]  B. Döme,et al.  Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging. , 2011, Journal of proteomics.

[63]  Liam A. McDonnell,et al.  Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma , 2011, PloS one.

[64]  Tyler Greer,et al.  Mass spectrometry imaging for drugs and metabolites. , 2011, Journal of proteomics.

[65]  F. Mégraud,et al.  Matrix-assisted laser-desorption/ionization biotyper: experience in the routine of a University hospital. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[66]  L. Hall,et al.  Performance and Cost Analysis of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Routine Identification of Yeast , 2011, Journal of Clinical Microbiology.

[67]  Pradeep S Rajendran,et al.  Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.

[68]  M. Karas,et al.  Compelling Evidence for Lucky Survivor and Gas Phase Protonation: The Unified MALDI Analyte Protonation Mechanism , 2011, Journal of the American Society for Mass Spectrometry.

[69]  Zoltan Takats,et al.  Mass spectrometry imaging with high resolution in mass and space (HR2 MSI) for reliable investigation of drug compound distributions on the cellular level , 2011, Analytical and bioanalytical chemistry.

[70]  S. Rauser,et al.  MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. , 2011, The American journal of pathology.

[71]  Richard M Caprioli,et al.  Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides , 2011, Inflammatory bowel diseases.

[72]  M. R. Groseclose,et al.  MALDI imaging mass spectrometry: bridging biology and chemistry in drug development. , 2011, Bioanalysis.

[73]  P. Chaurand,et al.  Sublimation of new matrix candidates for high spatial resolution imaging mass spectrometry of lipids: enhanced information in both positive and negative polarities after 1,5-diaminonapthalene deposition. , 2012, Analytical chemistry.

[74]  Brendan Prideaux,et al.  Mass spectrometry imaging for drug distribution studies. , 2012, Journal of proteomics.

[75]  Jorge S Reis-Filho,et al.  Genetic heterogeneity and cancer drug resistance. , 2012, The Lancet. Oncology.

[76]  Horst Zitzelsberger,et al.  Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. , 2012, Journal of proteome research.

[77]  N. Pavlidis,et al.  Cancer of unknown primary site , 2012, The Lancet.

[78]  R. Arceci.  Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2012 .

[79]  Claudio R. Santos,et al.  Lipid metabolism in cancer , 2012, The FEBS journal.

[80]  Carlo C. Maley,et al.  Clonal evolution in cancer , 2012, Nature.

[81]  Massimo Loda,et al.  Investigative pathology: leading the post-genomic revolution , 2012, Laboratory Investigation.

[82]  P. Kochanek,et al.  Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations. , 2012, Chemistry and physics of lipids.

[83]  Richard M Caprioli,et al.  Imaging Mass Spectrometry—A New and Promising Method to Differentiate Spitz Nevi From Spitzoid Malignant Melanomas , 2012, The American Journal of dermatopathology.

[84]  Stefan K. Maier,et al.  Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria , 2013, The Journal of pathology.

[85]  Richard M Caprioli,et al.  Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. , 2013, Chemical reviews.

[86]  Bernhard Kuster,et al.  Comprehensive Identification of Proteins from MALDI Imaging* , 2013, Molecular & Cellular Proteomics.

[87]  Theodore Alexandrov,et al.  Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas , 2013, Hepatology.

[88]  Malte Buchholz,et al.  MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large‐scale tissue microarrays , 2013, International journal of cancer.

[89]  M. Ohmura,et al.  Energy Management by Enhanced Glycolysis in G1-phase in Human Colon Cancer Cells In Vitro and In Vivo , 2013, Molecular Cancer Research.

[90]  Richard M Caprioli,et al.  Imaging mass spectrometry: A new tool for pathology in a molecular age , 2013, Proteomics. Clinical applications.

[91]  G. Cattoretti,et al.  Detection of high molecular weight proteins by MALDI imaging mass spectrometry. , 2013, Molecular bioSystems.

[92]  M. Zucchetti,et al.  Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging , 2013, PloS one.

[93]  M. Setou,et al.  Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4 , 2013, Cancer science.

[94]  Richard A Yost,et al.  Quantitative MALDI tandem mass spectrometric imaging of cocaine from brain tissue with a deuterated internal standard. , 2013, Analytical chemistry.

[95]  Lingjun Li,et al.  Qualitative and quantitative mass spectrometry imaging of drugs and metabolites. , 2013, Advanced drug delivery reviews.

[96]  M. Kwiatkowski,et al.  MALDI imaging on large‐scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer , 2013, Histopathology.

[97]  Bernhard Spengler,et al.  Mass spectrometry imaging with high resolution in mass and space , 2013, Histochemistry and Cell Biology.

[98]  A. Walch,et al.  Qualitative and quantitative mass spectrometry imaging of drugs and metabolites in tissue at therapeutic levels , 2013, Histochemistry and Cell Biology.

[99]  R. Casadonte,et al.  Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin‐fixed paraffin‐embedded tissues , 2014, Proteomics.

[100]  C. Borchers,et al.  Comprehensive imaging of porcine adrenal gland lipids by MALDI-FTMS using quercetin as a matrix. , 2014, Analytical chemistry.

[101]  Garry L Corthals,et al.  MSiMass list: a public database of identifications for protein MALDI MS imaging. , 2014, Journal of proteome research.

[102]  A. Feuchtinger,et al.  Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI , 2015, Analytical and Bioanalytical Chemistry.

[103]  A. Feuchtinger,et al.  Novel approach of MALDI drug imaging, immunohistochemistry, and digital image analysis for drug distribution studies in tissues. , 2014, Analytical chemistry.

[104]  M. Kwiatkowski,et al.  MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays. , 2014, Urologic oncology.

[105]  A. Walch,et al.  High‐resolution metabolite imaging of light and dark treated retina using MALDI‐FTICR mass spectrometry , 2014, Proteomics.

[106]  H. Schlüter,et al.  MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype. , 2014, Anticancer research.

[107]  André M Deelder,et al.  De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry , 2015, The Journal of pathology.